HypertensionNCT07762456
BATHE-Family Medicine
A study testing BATHE Therapeutic Interview Technique in people with Hypertension, run by Dokuz Eylul University at 1 site in Turkey (Türkiye).
Trial summary
This study evaluates the effect of the BATHE therapeutic interview technique on treatment adherence and blood pressure control in primary care hypertension patients. Hypertension patients aged 18-80 years were randomly assigned to an intervention or control group. Read more about this study
- Who is it for?
- Ages 18 to 80 years
- Conditions the study is for
- Hypertension
- What is being tested?
- BATHE Therapeutic Interview Technique
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 86 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 1 Oct 2020to 31 Jul 2021
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 80 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Diagnosed with hypertension for at least 6 months
- Aged between 18 and 80 years
- Registered at the family health center where the study was conducted
- Voluntary participation with signed informed consent
- Ability to use online video communication channels (e.g., WhatsApp or another video interview channel)
Who cannot join
- Presence of communication barriers
- Active psychiatric disease or current use of psychiatric medication
- Pregnancy
Trial locations and contacts
1 site in 1 country.
About this study
Official title: The Effect of Using the BATHE Therapeutic Interview Technique in Primary Care on Treatment Adherence in Hypertensive Patients
This study evaluates the effect of the BATHE therapeutic interview technique on treatment adherence and blood pressure control in primary care hypertension patients.
Hypertension patients aged 18-80 years were randomly assigned to an intervention or control group. The intervention group received the structured BATHE communication technique during clinical visits, while the control group received standard primary care counseling on drug adherence and lifestyle changes. Patients were followed for 6 months (visits at baseline, 3 months, and 6 months). Primary outcomes assessed include treatment adherence scores, drug compliance, and blood pressure levels.
Read the detailed description
Study Design:
A single-blind, randomized controlled intervention trial conducted in a primary care setting.
Intervention \& Control:
All visits were conducted by a single physician.
Intervention Group: Received 5-7 minute BATHE technique consultations (Background, Affect, Troubling, Handling, Empathy) along with routine lifestyle and medication advice.
Control Group: Received routine primary care advice on medication adherence and lifestyle changes.
Follow-up \& Measurements:
Visits occurred at baseline (face-to-face), 3 months (online video), and 6 months (face-to-face).
Blood pressure, BMI, and waist circumference were measured at baseline and 6 months.
Treatment adherence and medication compliance scales were administered at baseline and 6 months.
- Conditions
- Hypertension
- Being tested
- BATHE Therapeutic Interview Technique
- Keywords
- BATHE Technique, Treatment Adherence, Primary Health Care, Physician-Patient Relations
- Medical subject headings
- Hypertension, Treatment Adherence and Compliance
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
BATHE Therapeutic Interview TechniqueBehavioural
A brief psychotherapeutic consultation tool consisting of 5 steps: Background, Affect, Troubling, Handling, and Empathy, applied during clinical visits to enhance treatment adherence and patient self-efficacy.
| Study group | Role | What they receive |
|---|---|---|
| Intervention Group | Experimental | Participants received 5-7 minute BATHE technique consultations (Background, Affect, Troubling, Handling, Empathy) at baseline, 3 months, and 6 months, alongside routine primary care counseling on drug adherence and lifestyle modifications. Receives: Behavioral: BATHE Therapeutic Interview Technique |
| Control Group | No intervention | Participants received routine primary care counseling on drug adherence and lifestyle modifications routinely applied by the Department of Family Medicine at baseline, 3 months, and 6 months, without the BATHE technique. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in Treatment Adherence Scores
Assessed using the Scale for Evaluating the Success of Treatment Compliance and Lifestyle Change in Hypertensive Individuals (18 items, total score ranging from 18 to 90, with scores >= 68 indicating high treatment adherence).
Measured: Baseline and 6th month
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted13 Aug 2026
- Study start1 Oct 2020
- Primary completion30 Apr 2021
- Study completion31 Jul 2021
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for HypertensionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 86 participants (actual)
Sponsor and investigators
- Lead sponsor
- Dokuz Eylul University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Oğulcan Çöme, Dokuz Eylul University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07762456
- Sponsor's protocol ID
- 2021/06-32
- Status last verified
- Aug 2026
- First submitted
- 8 Aug 2026
- Last updated
- 13 Aug 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Sengul S, Akpolat T, Erdem Y, Derici U, Arici M, Sindel S, Karatan O, Turgan C, Hasanoglu E, Caglar S, Erturk S; Turkish Society of Hypertension and Renal Diseases. Changes in hypertension prevalence, awareness, treatment, and control rates in Turkey from 2003 to 2012. J Hypertens. 2016 Jun;34(6):1208-17. doi: 10.1097/HJH.0000000000000901.
PubMed 26991534
Study at a glance
From the registry record, last updated by the sponsor on 13 Aug 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effect of Using the BATHE Therapeutic Interview Technique in Primary Care on Treatment Adherence in Hypertensive Patients
- ClinicalTrials.gov ID
- NCT07762456
- Acronym / sponsor ID
- 2021/06-32
- Conditions
- Hypertension
- Keywords
- BATHE Technique, Treatment Adherence, Primary Health Care, Physician-Patient Relations
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 86 participants (actual)
- Lead sponsor
- Dokuz Eylul UniversityUniversity, hospital or other
- Study start
- 1 Oct 2020 (actual)
- Primary completion
- 30 Apr 2021 (actual)
- Study completion
- 31 Jul 2021 (actual)
- First posted
- 13 Aug 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study evaluates the effect of the BATHE therapeutic interview technique on treatment adherence and blood pressure control in primary care hypertension patients.
Hypertension patients aged 18-80 years were randomly assigned to an intervention or control group. The intervention group received the structured BATHE communication technique during clinical visits, while the control group received standard primary care counseling on drug adherence and lifestyle changes. Patients were followed for 6 months (visits at baseline, 3 months, and 6 months). Primary outcomes assessed include treatment adherence scores, drug compliance, and blood pressure levels.
Detailed description
Study Design:
A single-blind, randomized controlled intervention trial conducted in a primary care setting.
Intervention \& Control:
All visits were conducted by a single physician.
Intervention Group: Received 5-7 minute BATHE technique consultations (Background, Affect, Troubling, Handling, Empathy) along with routine lifestyle and medication advice.
Control Group: Received routine primary care advice on medication adherence and lifestyle changes.
Follow-up \& Measurements:
Visits occurred at baseline (face-to-face), 3 months (online video), and 6 months (face-to-face).
Blood pressure, BMI, and waist circumference were measured at baseline and 6 months.
Treatment adherence and medication compliance scales were administered at baseline and 6 months.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Intervention Group | Experimental | Behavioral: BATHE Therapeutic Interview TechniqueParticipants received 5-7 minute BATHE technique consultations (Background, Affect, Troubling, Handling, Empathy) at baseline, 3 months, and 6 months, alongside routine primary care counseling on drug adherence and lifestyle modifications. |
| Control Group | No intervention | –Participants received routine primary care counseling on drug adherence and lifestyle modifications routinely applied by the Department of Family Medicine at baseline, 3 months, and 6 months, without the BATHE technique. |
Who may qualify
- Ages
- 18 to 80 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (5 listed)
- Diagnosed with hypertension for at least 6 months
- Aged between 18 and 80 years
- Registered at the family health center where the study was conducted
- Voluntary participation with signed informed consent
- Ability to use online video communication channels (e.g., WhatsApp or another video interview channel)
Key exclusion criteria (3 listed)
- Presence of communication barriers
- Active psychiatric disease or current use of psychiatric medication
- Pregnancy
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| BATHE Therapeutic Interview TechniqueA brief psychotherapeutic consultation tool consisting of 5 steps: Background, Affect, Troubling, Handling, and Empathy, applied during clinical visits to enhance treatment adherence and patient self-efficacy. | Behavioural | Intervention Group |
Primary outcome
Change in Treatment Adherence Scores
Time frame: Baseline and 6th month
Assessed using the Scale for Evaluating the Success of Treatment Compliance and Lifestyle Change in Hypertensive Individuals (18 items, total score ranging from 18 to 90, with scores >= 68 indicating high treatment adherence).
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 13 Aug 2026.
- Background: PubMed 26991534Sengul S, Akpolat T, Erdem Y, Derici U, Arici M, Sindel S, Karatan O, Turgan C, Hasanoglu E, Caglar S, Erturk S; Turkish Society of Hypertension and Renal Diseases. Changes in hypertension prevalence, awareness, treatment, and control rates in Turkey from 2003 to 2012. J Hypertens. 2016 Jun;34(6):1208-17. doi: 10.1097/HJH.0000000000000901.
- Individual participant dataSharing planned: No
Related trials for Hypertension
Not yet recruiting
PAUL® Glaucoma Implant Safety and Effectiveness Study
Refractory Glaucoma
RecruitingObservational study
Asthma and Primary Arterial Hypertension: an Inflammatory Link?
Asthma Bronchial
RecruitingObservational study
Clevidipine for the Antihypertensive Treatment of Acute Intracerebral Hemorrhage
Intracerebral Hemorrhage, Stroke
RecruitingPhase 1/2
HS235 Study in Overweight and Obese Participants With Combined Pre and Post-Capillary Pulmonary Hypertension Due to Heart Failure With Preserved Ejection Fraction
Pulmonary Hypertension, Heart Failure With Preserved Ejection Fraction
Recruiting
Dry Weight Reduction Intervention Via Extra Ultrafiltration
Fluid Accumulation, Blood Pressure Management
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing BATHE Therapeutic Interview Technique in people with Hypertension, run by Dokuz Eylul University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 13 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in Treatment Adherence Scores (time frame: Baseline and 6th month). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07762456, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Aug 2026.